Clinical Trial Update: A Long-term Safety Extension Study of Tocilizumab in Brazilian Participants With Rheumatoid Arthritis (RA) Who Completed the Studies ML21530 and MA21488 [Phase 4]

View source ↗

Summary

Phase 4 long-term safety extension study of tocilizumab in Brazilian patients with rheumatoid arthritis who completed previous trials, assessing extended safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tocilizumab (Actemra) (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: COMPLETED | Results posted: 2017-06-12